Bharat Biotech: News
05 Jan 2021
IndiaGlobal leaders hail India's scientific innovation to combat COVID-19
Global leaders have lauded India's leadership in scientific innovation and decisive action to combat the COVID-19 pandemic.
05 Jan 2021
Serum Institute of IndiaSII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
04 Jan 2021
Ministry of Health and Family WelfareCOVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."
04 Jan 2021
Oxford UniversityBharat Biotech allowed COVAXIN trials on children aged 12+
Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.
03 Jan 2021
Drugs Controller General of IndiaAll you need to know about vaccines approved in India
Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.
03 Jan 2021
Drugs Controller General of IndiaSII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.
03 Jan 2021
Union Health MinistryCoronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
01 Jan 2021
PfizerIndia could approve coronavirus vaccine soon, key meeting today
After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.
21 Dec 2020
NITI AayogCoronavirus vaccination may start in January, says Health Minister
India may begin vaccinating people against coronavirus in January, Union Health Minister Dr. Harsh Vardhan said on Sunday, giving hope to a country that has lost more than a lakh to the fatal disease.
18 Dec 2020
IndiaCOVID-19 vaccine: India to produce 300 million Sputnik V doses
India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.
17 Dec 2020
Sri LankaIndia's neighbors train experts for clinical trials of COVID-19 vaccine
India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.
13 Dec 2020
All India Institute Of Medical Sciences (AIIMS)How Delhi plans to carry out COVID-19 vaccinations
Ahead of the licensing of a COVID-19 vaccine, the Delhi government has been working on a plan to conduct vaccinations.
12 Dec 2020
Times of IndiaHere's how the government is planning to conduct COVID-19 vaccinations
With licensing for COVID-19 vaccines expected in the coming weeks, the government has drafted a plan for vaccination campaigns.
09 Dec 2020
Serum Institute of IndiaNo emergency approval for SII, Bharat Biotech's vaccine candidates yet
Two applications submitted by the Pune-based Serum Institute of India and Hyderabad-based Bharat Biotech seeking emergency approval for their respective COVID-19 vaccines have not been cleared, NDTV reported on Wednesday.
08 Dec 2020
NITI AayogCOVID-19 vaccine may get license in coming weeks: Health Ministry
India may license some COVID-19 vaccines in the next few weeks, the Union Health Ministry said on Tuesday.
08 Dec 2020
Indian Council of Medical Research (ICMR)Now, Bharat Biotech seeks emergency use approval for COVAXIN
After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.
28 Nov 2020
Narendra ModiModi embarks on 3-city tour to view COVID-19 vaccine development
Prime Minister Narendra Modi on Saturday embarked on a three-city tour to review the development of COVID-19 vaccines.
22 Nov 2020
Indian Council of Medical Research (ICMR)Bharat Biotech vaccine trials continued despite 'adverse event' in August
Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.
07 Nov 2020
VaccineCOVAXIN: Doctors, nurses, MBBS students to get first vaccine doses
Health workers will be among the first 30 crore people to be administered Bharat Biotech's COVID-19 vaccine.
05 Nov 2020
IndiaBharat Biotech's coronavirus vaccine could be out by February 2021
The coronavirus vaccine being developed by Bharat Biotech could be launched by February, months earlier than expected, an official from the Indian Council of Medical Research (ICMR), told Reuters on Thursday.
31 Oct 2020
IndiaAIIMS to submit proposal for COVAXIN's phase three trials soon
By early next week, AIIMS will submit a proposal to start the third phase of clinical trials of COVAXIN, a vaccine against coronavirus being developed by Bharat Biotech.
24 Oct 2020
VaccineCoronavirus: Bharat Biotech aims to launch COVAXIN by June 2021
Hyderabad-based pharmaceutical firm Bharat Biotech is expecting to launch its coronavirus vaccine candidate, COVAXIN, by June next year.
23 Sep 2020
Washington UniversityBharat Biotech signs deal for nasal COVID-19 vaccine: Details here
In a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States.
12 Sep 2020
CoronavirusCOVAXIN animal trials confirmed to be successful: Details here
In a major development, Bharat Biotech has announced that its homegrown COVID-19 vaccine candidate - COVAXIN - has proven successful in animal trials.
22 Aug 2020
All India Institute Of Medical Sciences (AIIMS)Bharat Biotech gets approval to test COVAXIN administration through skin
Hyderabad-based Bharat Biotech has been allowed to conduct a trial to test administer its COVID-19 vaccine candidate through the skin (intradermal vaccine delivery).
14 Aug 2020
All India Institute Of Medical Sciences (AIIMS)COVAXIN: India's COVID-19 vaccine found safe in early trial
COVAXIN, the first indigenously developed COVID-19 vaccine from India, has proven to be safe in early human trials.
07 Aug 2020
IsraelIsrael claims to have 'excellent' COVID-19 vaccine in hand
Israel says it has an 'excellent' vaccine in hand to prevent COVID-19, the novel coronavirus disease.
04 Aug 2020
VaccineCOVAXIN will cost less than water bottle: Bharat Biotech MD
Ever since companies started developing vaccines for COVID-19, one big question has been on everyone's mind: how much the final, approved shot would cost to the public?
04 Aug 2020
All India Institute Of Medical Sciences (AIIMS)AIIMS vaccine trials: 80% volunteers found unfit for study
Nearly two weeks ago, AIIMS Delhi had started the Phase 1 human trial of COVAXIN — the first candidate vaccine developed indigenously in India to fight the spread of COVID-19.
26 Jul 2020
VaccineCOVAXIN: First part of phase 1 trials complete; results encouraging
The first part of phase I trials of India's first indigenous COVID-19 vaccine candidate has completed and the results are said to be encouraging.
24 Jul 2020
All India Institute Of Medical Sciences (AIIMS)AIIMS Delhi starts human trials of India's first COVID-19 vaccine
The All India Institute of Medical Science (AIIMS) in Delhi has started human trials of COVAXIN, the country's first indigenously developed vaccine to prevent the novel coronavirus disease COVID-19.
17 Jul 2020
VaccineIndia's COVID-19 vaccines: What are the latest updates?
In the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.
09 Jul 2020
VaccineAll you need to know about India's COVID-19 vaccines
As the coronavirus outbreak continues to surge worldwide, efforts to develop a vaccine have been expedited.
07 Jul 2020
Indian Council of Medical Research (ICMR)Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable
On July 2, the Indian Council of Medical Research (ICMR) revealed its plans to launch COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech and ICMR, by August 15.
05 Jul 2020
OxfordCOVID-19 vaccine: What are the latest updates?
With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.
04 Jul 2020
VaccineFollowing globally-accepted norms, says ICMR over August 15 vaccine target
The Indian Council of Medical Research (ICMR) on Saturday said that it is acting in accordance with globally-accepted norms by setting a mid-August target for developing a COVID-19 vaccine.
03 Jul 2020
Drugs Controller General of IndiaIndia's second COVID-19 vaccine cleared for human trials: Details here
India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.
03 Jul 2020
Indian Council of Medical Research (ICMR)India targets to launch first COVID-19 vaccine by August 15
In a major development, the Indian Council of Medical Research (ICMR) has announced its plan to launch a COVID-19 vaccine for public use by August 15.
30 Jun 2020
CoronavirusIndia's first COVID-19 vaccine, COVAXIN, cleared for human trials
In a major development, the Drug Controller General of India (DCGI) has cleared COVAXIN, a potential COVID-19 vaccine developed in the country, for human trials.
10 May 2020
Indian Council of Medical Research (ICMR)ICMR, Bharat Biotech teaming up to develop Indian COVID-19 vaccine
In a major development, the Indian Council of Medical Research (ICMR) is teaming up with Bharat Biotech International Limited (BBIL) to develop the first "Make-in-India" vaccine for COVID-19 or the novel coronavirus disease.